Cataract surgery-induced dry eye may not be a direct consequence of surgery

Article

Dry eye following cataract surgery may not be a direct result of the surgery but rather the surgery triggers symptoms in eyes with pre-existing sub-optimal tear properties.

Dry eye following cataract surgery may not be a direct result of the surgery but rather the surgery triggers symptoms in eyes with pre-existing sub-optimal tear properties, according to Waheeda Illahi and colleagues from BMEC, City Hospital, Birmingham, UK.

A study was conducted to assess tear quantity, break-up time and central corneal thickness following cataract surgery. Tear quantity was measured using a phenol red thread, fluorescein break-up time (measured in seconds) was quantified by standard biomicroscopy and central corneal thickness was measured by ultrasonic pachymetry after topical anaesthesia. Measurements were taken from right eyes in bilateral cases and age and gender matched controls.

The results showed that mean phenol red thread was 16.9 mm in the study group and 16.5 mm in the controls. Mean break-up time was 4.9 seconds in the study group and 4.6 seconds in the controls. Mean central corneal thickness was 541.2 µm in the study group and 539.0 µm in the controls. Comparisons revealed no statistical differences between the two groups but there was a significant correlation between break-up time and phenol red thread in the study group (r=0.265, p=0.028).

Although dry eye symptoms are often reported after cataract surgery, this study suggests that surgery is not the direct cause but rather that the surgery triggers symptoms in eyes with pre-existing sub-optimal tear properties.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.